# Curium to merge with Lantheus in $8B deal

Curium US Holdings agreed to acquire Lantheus for $102.50 per share in cash at closing plus up to $12.00 per share in contingent value rights, for a total transaction value of up to $8.0 billion.

- Type: Acquisition
- Announced: 2018-01-21
- Where: United States
- Value: $8.00B
- Status: announced
- Products: radiopharmaceuticals, theranostics, radiodiagnostics
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Lantheus Holdings](https://endata.com/companies/23794.md) (target)
- [Curium](https://endata.com/companies/29511.md) (acquirer)

## Sources

- [indovizka.com](https://indovizka.com/news/detail/22158/curium-announces-definitive-agreement-to-merge-with-lantheus), 2018-01-21: "Together, Curium and Lantheus are positioned to create a radiopharmaceutical company spanning diagnostics and therapeutics, with the infrastructure and capabilities to serve patients in more than 70 countries."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.